System Alert

Reminder: 45 CFR Part 75, Subpart F requires recipients expending $750,000 or more in Federal awards during their FYs to complete Single Audits and submit the related reports to the Federal Audit Clearinghouse (FAC) within 9 months after the end of their audit periods. Please email SARFollowUp@hrsa.gov with questions.

 

System Alert

HRSA has been informed that multiple phishing emails were sent to HRSA grantees. The impersonating phishing emails include a link to a fake site instructing grantees to enter Personally Identifiable Information (PII), including SSN, Driver’s License, and Tax information. HRSA will never send you an email asking you to click a link and confirm your email address or other user personal information.

Please remain vigilant when you receive emails to ensure that they are from a legitimate HRSA user and not an email impersonating a HRSA email address. You can hover over the email address to confirm its origin.

If you have submitted such information, please contact your internal IT security team for assistance. Also, if you have provided any personally identifiable information (PII), please visit https://www.ic3.gov/ to file a complaint. IC3 website is managed by a law enforcement agency.

If you have submitted such information, please also inform your HRSA Grant Project Officer and/or EHBs Customer Support Center using the Contact Form or calling 877-464-4772 that your PII may have been exposed.

Skip to Main Content

HRSA Electronic Handbooks

Funding Cycle View

Expand

Hereditary Hemorrhagic Telangiectasia (HHT) Center

  • Program Name:Hereditary Hemorrhagic Telangiectasia (HHT) Program
  • Activity Code:UP4
  • Application Available:3/18/2022
  • Application Deadline:5/17/2022
  • Created By:Wildberger, William
  • Created On:1/6/2022
  • Last Updated by:Wildberger, William
  • Last Updated On:3/18/2022
  • Estimated Project Start Date:9/30/2022
 
Collapse

 Details of the changes posted in this announcement

Not Available
 
Collapse

 Announcement Information

Announcement Number HRSA-22-145
Announcement Code
CFDA Number 93.110
Provisional No
Activity Code UP4
Competitive Yes
Fiscal Year 2022
 
Collapse

 Purpose

The Health Resources and Services Administration (HRSA) is accepting applications for the fiscal year (FY) 2022 Hereditary Hemorrhagic Telangiectasia (HHT) Center. The purpose of the program is to reduce morbidity and mortality associated with hereditary hemorrhagic telangiectasia by funding a national center to: 1) expand access to and coordination of care for HHT patients; and 2) develop a de-identified, aggregate data collection registry to better understand this rare disease and treatment outcomes.
 
Collapse

 Application Information

Application Available 03/18/2022
Application Deadline 05/17/2022
Supplemental Application Deadline N/A
Explanation for Deadline N/A
Archive Date 07/16/2022
Letter of Intent Not required
Application Package SF424
Allow Applications to be Reopened in EHBs No
FOA Available Yes
Competitive Application Types Supported New
Allow Electronic Submission N/A
Page Limit for Application
Attachments
50
Allow Multiple Applications
from an Organization from Grants.gov
No
Electronic Submission Instruction Electronic submission is/will be available in Grants.Gov
 
Collapse

 General Information

Projected Award Date N/A
Estimated Project Period N/A
Estimated Project Start Date 09/30/2022
Estimated Project End Date 09/29/2025
Estimated Amount of this Competition $2,000,000.00
Estimated Number of Awards 1
Estimated Average Size of Awards $2,000,000.00
Cost Sharing No
Cooperative Agreement Yes
 
Collapse

 Contact Information

Name Cristina Novoa, Ph.D.
Email cnovoa@hrsa.gov
Phone Number (301) 443-1463
 
Collapse

 Download Information

Expand FOA (Guidance) Attachment (Maximum 1)
Document Name Size Date Attached Description
MCHB HRSA-22-145 (UP4) HHT_Final.pdf 387 kB 03/18/2022
Expand Application Package (Maximum 1)
No documents attached
Expand User Guide (Maximum 1)
No documents attached


Scroll to top